High Net Worth Advisory Group LLC Regeneron Pharmaceuticals, Inc. Transaction History
High Net Worth Advisory Group LLC
- $345 Million
- Q4 2024
A detailed history of High Net Worth Advisory Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 302 shares of REGN stock, worth $200,485. This represents 0.06% of its overall portfolio holdings.
Number of Shares
302
Previous 302
-0.0%
Holding current value
$200,485
Previous $317,000
32.18%
% of portfolio
0.06%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
84.6MCall Options Held
1.29MPut Options Held
1.47M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.16 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.61 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.69 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.25 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.85 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $71.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...